NZM2:ETR
Novozymes A/S
58,00 €
0,00%
(0,00) 1D
8. lis, 17:35:57 GMT+2 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za NZM2...
Otvori
57,88 €
Najviša
58,00 €
Najniža
57,52 €
Trž. kap.
178,87 mlr.
Prosj. kol.
120,00
Količina
9,00
52-tjed. najviša
61,96 €
52-tjed. najniža
46,74 €
Broj djelatnika
11 tis.
Otvori
57,88 €
Najviša
58,00 €
Najniža
57,52 €
Trž. kap.
178,87 mlr.
Prosj. kol.
120,00
Količina
9,00
52-tjed. najviša
61,96 €
52-tjed. najniža
46,74 €
Broj djelatnika
11 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
AD HOC NEWS
·
prije 20 sati
Novonesis stock gets a higher target at 420 DKK
Simply Wall Street
·
prije 2 dana
How Investors Are Reacting To Novonesis Stock As US Dairy Capacity Expands
Profil
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, Greater Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
Novozymes A/S – informacije
Glavni izvršni direktorEster Baiget
Zaposlenici11,1 tis.
Osnovano2000
Sjedište-
SektorSpeciality chemicals
Web-lokacijanovonesis.com